Father Francis McNutt Passes Away

1,193 Views | 0 Replies | Last: 4 yr ago by dermdoc
UTExan
How long do you want to ignore this user?
Quote:

He was ordained as a Dominican priest in 1956 and completed his Ph.D. in theology from Aquinas Institute of Theology where he excelled as a professor of preaching. With an extensive background in speech and drama, and gifts in preaching and communication, he was elected president of the National Catholic Homiletics Society and founded the journal Preaching in 1965. He also authored the book Evaluating Preaching Effectiveness and held seminars on preaching throughout the United States.

In 1967, Francis' life took a dramatic and unexpected turn when he experienced the baptism of the Holy Spirit at a Camp Farthest Out conference. That conference became the watershed event of his life. There he met Agnes Sanford, a pioneer in the healing prayer and pastoral care movement, who became his mentor, and Rev. Tommy Tyson, a Methodist minister and leader in the charismatic movement, who became his lifelong friend. Tommy traveled with Francis and his ministry team throughout the world on healing missions. Francis founded Merton House in St. Louis, a non-profit ministry that focused on life in the Holy Spirit and healing prayer, as well as living with and among the poor.

https://www.charismanews.com/us/79722-francis-macnutt-leader-in-catholic-charismatic-renewal-dies-at-94
Well done, faithful servant. Thanks for your service to the people of God unrestricted by denominational prejudices or boundaries.
It is better to light a flamethrower than to curse the darkness- Sir Terence Pratchett
“ III stooges si viveret et nos omnes ad quos etiam probabile est mittent custard pies”
dermdoc
How long do you want to ignore this user?
AG
Amen.
No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. See full Medical Disclaimer.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.